Cat.No | Product Name | CAS | Size |
A137136 | Ibotenic acid (mGlu1, mGlu5 receptor full agonist) | 2552-55-8 | 1mg;5mg;10mg;25mg;50mg |
A283251 | Ammonium tetraborate tetrahydrate (TLR2 agonist) | 12228-87-4 | 500g |
A302770 | Amarogentin (TAS2R30, TAS2R43, TAS2R46, TAS2R50 agonist) | 21018-84-8 | 10mg;50mg;100mg |
A348021 | Arecoline (M2, M3, M4 receptor full agonist) | 63-75-2 | 10mg;50mg;250mg;1g |
A348021 | Arecoline (M1 receptor partial agonist) | 63-75-2 | 10mg;50mg;250mg;1g |
A348021 | Arecoline (M5 receptor agonist) | 63-75-2 | 10mg;50mg;250mg;1g |
A412888 | Absinthin (TAS2R30, TAS2R46 agonist) | 1362-42-1 | 1mg;5mg;10mg;25mg;50mg |
B101534 | Betulinic acid (GPBA receptor full agonist) | 472-15-1 | 20mg |
B106473 | Biochanin A (Estrogen-related receptor-α, β, γ agonist) | 491-80-5 | 50mg |
B129941 | Budesonide (Glucocorticoid receptor agonist) | 51333-22-3 | 50mg;100mg;250mg;1g;5g |
B129941 | Budesonide (Mineralocorticoid receptor agonist) | 51333-22-3 | 50mg;100mg;250mg;1g;5g |
B129941 | Budesonide (Progesterone receptor agonist) | 51333-22-3 | 50mg;100mg;250mg;1g;5g |
C139833 | A23187, Mixed Ca/Mg salt (TAS2R43, TAS2R46 agonist) | 52665-69-7 (free acid) | 5mg;25mg |
C274895 | Cabergoline (5-HT1A, 5-HT1B receptor full agonist) | 81409-90-7 | 5mg;10mg;25mg;50mg;100mg |
C274895 | Cabergoline (5-HT2A, 5-HT2B, 5-HT2C receptor full agonist) | 81409-90-7 | 5mg;10mg;25mg;50mg;100mg |
C274895 | Cabergoline (5-HT1D receptor partial agonist) | 81409-90-7 | 5mg;10mg;25mg;50mg;100mg |
C274895 | Cabergoline (D1, D5 receptor full agonist) | 81409-90-7 | 5mg;10mg;25mg;50mg;100mg |
C274895 | Cabergoline (D2, D3, D4 receptor partial agonist) | 81409-90-7 | 5mg;10mg;25mg;50mg;100mg |
C348066 | Cucurbitacin B (TAS2R10 agonist) | 6199-67-3 | 5mg;25mg;100mg |
D106438 | Daidzein (Estrogen-related receptor-α, β, γ agonist) | 486-66-8 | 1g;5g;25g |
D129472 | Difluprednate (Glucocorticoid receptor agonist) | 23674-86-4 | 50mg;100mg;500mg |
D336104 | DL-Goitrin (TAS2R38 agonist) | 13190-34-6 | 10mg;25mg;100mg |
E100888 | (-)-Epigallocatechin (EGC) (TAS2R39 agonist) | 970-74-1 | 10mg;50mg;250mg;1g |
E101658 | (-)-Epicatechin gallate (TAS2R39 agonist) | 1257-08-5 | 10mg;50mg |
E107404 | (-)-Epicatechin gallate (TAS2R5 agonist) | 989-51-5 | 100mg;500mg;2.5g |
E135009 | Embelin (GPR84 agonist) | 550-24-3 | 5mg;25mg;100mg;250mg |
E431516 | Erythromycin standard solution (motilin receptor full agonist) | 114-07-8 | 10ml |
E432751 | (−)-Epicatechin (TAS2R39 agonist) | 490-46-0 | 1g;5g |
G288904 | Grifolic acid (FFA4 receptor partial agonist) | 80557-12-6 | 1mg |
H275963 | Hyperforin (Pregnane X receptor agonist) | 11079-53-1 | 500μg;1mg;5mg |
K276587 | Kainic acid (GluK1, GluK2, GluK3, GluK4, GluK5 full agonist) | 487-79-6 | 10mM/ml |
L107328 | Luteolin (TAS2R14, TAS2R39 agonist) | 491-70-3 | 20mg;2g |
L107709 | Lovastatin (Pregnane X receptor full agonist) | 75330-75-5 | 1g;5g;25g;100g |
L353949 | Lisuride (5-HT1A, 5-HT7 receptor full agonist) | 18016-80-3 | 0.25mg;1mg;10mg |
L353949 | Lisuride (5-HT1B, 5-HT1D receptor partial agonist) | 18016-80-3 | 0.25mg;1mg;10mg |
L353949 | Lisuride (5-HT2A, 5-HT2C, 5-HT6 receptor partial agonist) | 18016-80-3 | 0.25mg;1mg;10mg |
L353949 | Lisuride (D1, D2, D3, D4, D5 receptor partial agonist) | 18016-80-3 | 0.25mg;1mg;10mg |
L355093 | Lupulone (TAS2R14 agonist) | 468-28-0 | 2mg |
M101152 | 5-Methoxypsoralen (TAS2R10 agonist) | 484-20-8 | 20mg |
M115185 | 8-Methoxypsoralen (TAS2R20 agonist) | 298-81-7 | 20mg |
N130078 | Nobiletin (TAS2R14 agonist) | 478-01-3 | 10mg;50mg;100mg |
N357056 | Nickel(II) cyanide tetrahydrate (TLR4, TLR5 agonist) | 13477-95-7 | 10g |
O101532 | Oleuropein (TAS2R8 agonist) | 32619-42-4 | 20mg |
O110088 | Oleanolic acid (GPBA receptor full agonist) | 508-02-1 | 100mg;500mg;1g;5g; 25g;100g;500g |
P102441 | L-(-)-3-Phenyllactic acid (HCA3 receptor agonist) | 20312-36-1 | 1g;5g;25g;100g |
P103807 | Phenyl β-D-glucopyranoside (TAS2R16 agonist) | 1464-44-4 | 1g;5g;25g |
P106868 | Paclitaxel (Pregnane X receptor agonist) | 33069-62-4 | 10mg |
P106868 | Paclitaxel (TLR4 agonist) | 33069-62-4 | 10mg |
P110661 | N-Phenylthiourea (TAS2R38 agonist) | 103-85-5 | 5g;25g;100g;500g |
P115736 | Parthenolide (TAS2R14, TAS2R8 agonist) | 20554-84-1 | 20mg |
P127748 | Phloretin (TAS2R14, TAS2R39 agonist) | 60-82-2 | 250mg;1g;5g;25g;100g |
P134941 | p-Nitrophenyl β-D-Mannopyranoside (TAS2R16 agonist) | 35599-02-1 | 5mg;25mg;100mg |
P160369 | (±)-Equol (TAS2R14, TAS2R39 agonist) | 94105-90-5 | 50mg;200mg;250mg; 1g;5g;25g;100g |
P160441 | Pergolide (5-HT1A, 5-HT1D, 5-HT2C receptor partial agonist) | 66104-22-1 | 10mg;50mg;100mg;250mg |
P160441 | Pergolide (5-HT1B, 5-HT2A, 5-HT2B receptor full agonist) | 66104-22-1 | 10mg;50mg;100mg;250mg |
P160441 | Pergolide (5-HT6, 5-HT7 receptor full agonist) | 66104-22-1 | 10mg;50mg;100mg;250mg |
P160441 | Pergolide (Alpha-2A, 2B, 2C adrenoceptor partial agonist) | 66104-22-1 | 10mg;50mg;100mg;250mg |
P160441 | Pergolide (D1, D2, D5 receptor full agonist) | 66104-22-1 | 10mg;50mg;100mg;250mg |
P160441 | Pergolide (D3, D4 receptor partial agonist) | 66104-22-1 | 10mg;50mg;100mg;250mg |
P346776 | Pergolide (TAS2R14, TAS2R46 agonist) | 17617-45-7 | 5mg;10mg;25mg; 50mg;100mg;250mg |
Q105030 | Quinine (TAS2R14, TAS2R40 agonist) | 130-95-0 | 1g;5g;25g;100g |
R105455 | Rifampicin (Pregnane X receptor agonist) | 13292-46-1 | 250mg;1g;5g;25g;100g;500g |
R107314 | Resveratrol (TAS2R14 agonist) | 501-36-0 | 100mg |
R136822 | (±)-Naringenin (TAS2R39 agonist) | 67604-48-2 | 1g;2g;5g;25g;100g; |
S104922 | D(-)-Salicin (TAS2R16 agonist) | 138-52-3 | 5g;25g;100g |
S109808 | Silibinin (TAS2R14 agonist) | 22888-70-6 | 20mg |
S115189 | Schisandrin A (Pregnane X receptor agonist) | 61281-38-7 | 20mg |
S138949 | Scutellarein (TAS2R39 agonist) | 529-53-3 | 5mg;25mg;100mg;250mg |
S161431 | Santonin (TAS2R14 agonist) | 481-06-1 | 1g;5g;25g |
S275638 | Salvinorin A (KOR full agonist) | 83729-01-5 | 1mg;5mg |
T100847 | Santonin (TAS2R20 agonist) | 32986-56-4 | 1g;5g;25g;100g |
T107164 | Tobramycin (FFA2 receptor full agonist) | 80-59-1 | 5g;25g;100g;500g |
U166815 | Ulipristal acetate (Progesterone receptor partial agonist) | 126784-99-4 | 10mg;50mg;250mg;1g |
V431596 | Vanillin (TAS2R14, TAS2R20, TAS2R39 agonist) | 121-33-5 | 1kg;25kg |
V431596 | Vanillin (TRPV3 agonist) | 121-33-5 | 1kg;25kg |